sample - global mhealth (mobile health) market

GLOBAL MHEALTH (MOBILE HEALTH) MARKET

Focus on Ecosystem (mHealth Devices & Services), Therapeutics, Application/ Solution Type & Regions

– Estimation & Forecast through 2015 to 2022

BIS Research Sample

Global mHealth (Mobile Health) Market: Focus on Ecosystem (mHealth Devices & Services),

Therapeutics, Application/ Solution Type & Regions – Estimation & Forecast through 2015 to 2022

BIS Research is a leading market intelligence and technology research company. BIS Research

publishes in-depth market intelligence reports focusing on the market estimations, technology

analysis, emerging high-growth applications, deeply segmented granular country-level market

data and other important market parameters useful in the strategic decision making for senior

management. BIS Research provides multi-client reports, company profiles, databases, and

custom research services.

Copyright © 2014 BIS Research

All Rights Reserved. This document contains highly confidential information and is the sole

property of BIS Research. Disclosing, copying, circulating, quoting or otherwise reproducing

any or all contents of this document is strictly prohibited. Access to this information is provided

exclusively for the benefit of the people or organization concerned. It may not be accessed by,

or offered whether for sale or otherwise to any third party.

BIS Research Sample



TABLE OF CONTENTS

1 REPORT SCOPE ..................................................................................................... 21

1.1 SCOPE OF THE STUDY ............................................................... 21

1.1.1 MOBILE HEALTH (MHEALTH): REPORT COVERAGE .......... 21

1.1.2 BIS RESEARCH METHODOLOGY ...................................... 22

1.1.3 RESEARCH METHODOLOGY FOR THE GLOBAL

MARKET STUDY .............................................................. 24

1.1.3.1 Geographical Analysis ................................................ 24

1.1.3.2 Demand Side & Supply Side Analysis ............................ 25

1.1.3.3 Data Synthesis & Bridging .......................................... 25

1.1.4 GLOBAL MOBILE HEALTH (MHEALTH): RESEARCH METHODOLOGY .............................................................. 26

1.1.5 KEY DATA POINT SOURCES ............................................ 27

1.1.5.1 Data Points taken from Secondary Sources ................... 27

1.1.5.2 Data Points taken from Primary Sources ....................... 27

1.1.6 REPORT DESCRIPTION ................................................... 28

2 EXECUTIVE SUMMARY ....................................................................................... 32

3 MARKET OVERVIEW ........................................................................................... 36

3.1 INTRODUCTION ........................................................................ 36

3.2 MARKET DYNAMICS .................................................................. 36

3.2.1 MARKET DRIVERS .......................................................... 37

3.2.1.1 Patients Involvement in personal healthcare .................. 39

3.2.1.2 Proliferation of Smartphones and wearable devices into healthcare .......................................................... 40

3.2.1.3 Integration of wireless technologies with portable

healthcare devices ..................................................... 41

3.2.1.4 Introduction of connected healthcare solutions in the mHealth market ........................................................ 42

3.2.1.5 Benefits of Cost effectiveness and Patients’ Convenience ............................................................. 43

3.2.1.6 Increase in Lifestyle Disease ....................................... 44

3.2.2 MARKET CHALLENGES .................................................... 45

BIS Research Sample



3.2.2.1 Low rate of literacy and language barriers in low- and middle-income countries (LMICs) ........................... 45

3.2.2.2 Invasion of Privacy .................................................... 46

3.2.2.2.1 Security Breach Cases ...................................... 47

3.2.2.2.2 Potential risk of Hardware or Software failure ....... 48

3.2.2.2.3 Stringent Regulations and Standards .................. 48

3.2.2.2.4 Lack of Awareness about the possible applications of mHealth ..................................... 50

3.2.3 MARKET OPPORTUNITIES .............................................. 50

3.2.3.1 Partnership: An entry mode ........................................ 50

3.2.3.2 Introduction of mHealth in developing economies ........... 51

4 INDUSTRY DYNAMICS......................................................................................... 53

4.1 MHEALTH MARKET TIMELINE .................................................... 53

4.2 VALUE CHAIN OF THE MHEALTH MARKET ................................. 54

4.2.1.1 Device Manufacturers ................................................. 55

4.2.1.2 App Developers ......................................................... 55

4.2.1.3 Network providers/ Mobile operators ............................ 56

4.2.1.4 Healthcare providers and Pharmaceuticals..................... 56

4.2.1.5 Patients ................................................................... 56

4.2.1.6 Consortiums, Certification, Regulations, & Standards ...... 57

4.2.1.6.1 Introduction .................................................... 57

4.2.1.6.2 Consortiums .................................................... 58

4.2.1.6.3 Alliance/Associations ........................................ 60

4.2.1.6.4 Regulatory Bodies ............................................ 62

4.2.1.7 Food and Drug Administration (FDA) ............................ 66

4.2.1.8 Medical Device Regulation Act ..................................... 66

4.2.1.9 Medical Mobile Application(MMA) ................................. 67

4.2.2 CERTIFICATION ............................................................. 67

4.2.3 MHEALTH DEVICE: PORTER’S FIVE FORCE ANALYSIS...... 69

4.2.4 BARGAINING POWER OF BUYER ..................................... 70

4.2.5 BARGAINING POWER OF SUPPLIER ................................ 71

4.2.6 THREAT FROM SUBSTITUTE ............................................ 72

4.2.7 THREAT FROM A NEW ENTRANT ..................................... 73

4.2.8 INTENSITY OF COMPETITIVE RIVALRY ........................... 74

BIS Research Sample



5 GLOBAL MHEALTH MARKET ECOSYSTEM ................................................... 76

5.1 INTRODUCTION ........................................................................ 76

5.1.1 MHEALTH DEVICES ......................................................... 78

5.1.2 MEDICAL DEVICES ......................................................... 82

5.1.2.1 SMBG monitor ........................................................... 82

5.1.2.1.1 SMBG Device Types& Uses ................................ 82

5.1.2.1.2 Diseases Managed by SMBG Device .................... 83

5.1.2.1.3 Key players ..................................................... 84

5.1.2.2 Blood Pressure (BP) Monitor ........................................ 84

5.1.2.2.1 BP Monitor Device Types & Uses ......................... 85

5.1.2.2.2 Diseases Managed by BP Monitor Device.............. 86

5.1.2.2.3 Key players ..................................................... 86

5.1.2.2.4 Pulse Oximeter ................................................ 86

5.1.2.2.5 Pulse Oximeter : Types & Uses ........................... 87

5.1.2.2.6 Diseases Managed by Pulse Oximeter Device........ 87

5.1.2.2.7 Key players ..................................................... 88

5.1.2.3 Cardiac Monitors ....................................................... 88

5.1.2.3.1 Diseases Managed by Cardiac Monitors ............... 88

5.1.2.3.2 Disease Management Devices Types ................... 88

5.1.2.3.3 Cardiac Monitor Uses ........................................ 89

5.1.2.4 Key players .............................................................. 89

5.1.2.5 Other medical devices ................................................ 89

5.1.2.5.1 Health and Fitness Devices ................................ 89

5.1.2.5.2 Hand Worn Products ......................................... 91

5.1.2.5.2.1 Smart Watch .................................................... 92

5.1.2.5.2.2 Wrist Wear ....................................................... 92

5.1.2.5.3 Key players ..................................................... 93

5.1.2.5.4 Head Worn Products ......................................... 93

5.1.2.5.4.1 AR/VR HMD/HUD .............................................. 95

5.1.2.5.4.2 Others ............................................................. 95

5.1.2.5.4.3 Body worn products .......................................... 96

5.1.2.5.4.4 Smart Textile ................................................... 96

5.1.2.5.4.5 Wearable Patch................................................. 97

5.1.2.5.4.6 Others ............................................................. 98

5.1.2.5.5 Non-Clinical applications ................................. 100

BIS Research Sample



5.1.2.5.6 Clinical Application ......................................... 102

5.1.2.6 Others Devices ........................................................ 105

5.1.2.6.1 Mobile telemedicine/tele-care devices ............... 105

5.1.2.6.2 Home care devices ......................................... 105

5.1.2.6.2.1 Vessyl ........................................................... 105

5.1.2.6.2.2 TAO .............................................................. 105

5.1.2.6.2.3 CubeSensors .................................................. 105

5.1.2.6.2.4 Kolibree ......................................................... 106

5.1.2.6.2.5 TellSpec ......................................................... 106

5.1.2.6.2.6 Kinsa ............................................................. 106

5.1.2.6.2.7 Beddit ........................................................... 106

5.1.2.6.2.8 Wello iPhone Case ........................................... 106

5.1.2.6.3 Key Participants ............................................. 106

5.1.2.7 mHealth Services .................................................... 106

5.1.3 MOBILE HEALTH APPS AND CONTENT SOLUTION ......... 110

5.1.3.1 Software ................................................................ 110

5.1.3.2 Big data ................................................................. 113

5.1.3.3 Key Market Trends, Developments and Participants ...... 115

5.1.3.3.1 Market Trends and Market Developments .......... 115


5.1.4 NETWORK AND SERVICES/ MOBILE OPERATORS .......... 116

5.1.4.1 Benefits of network & Services .................................. 117




5.1.5 HEALTHCARE AND PHARMACEUTICALS ........................ 120

5.1.5.1 Healthcare providers ................................................ 120

5.1.5.2 Pharmaceuticals ...................................................... 121

5.1.5.2.1 Key Market Trends, Developments and

Participants ................................................... 121

5.1.5.2.1.1 Market Trends and Market Developments .......... 122

5.1.5.2.1.2 Key Participants .............................................. 123

6 GLOBAL MHEALTHMARKET – THERAPEUTICS .......................................124

6.1 INTRODUCTION ...................................................................... 124

6.1.1 GLOBAL MARKET STATISTICS ....................................... 125

BIS Research Sample



6.1.1.1 Cardiovascular Diseases ........................................... 126

6.1.2 DEVICES ...................................................................... 128

6.1.3 APPS ............................................................................ 129

6.1.4 KEY PLAYERS ............................................................... 132

6.2 DIABETES ............................................................................... 132

6.2.1 DEVICES ...................................................................... 135

6.2.2 APPS ............................................................................ 135

6.2.3 KEY PLAYERS ............................................................... 137

6.3 RESPIRATORY ......................................................................... 137

6.3.1 DEVICES ...................................................................... 140

6.3.2 APPS ............................................................................ 140

6.3.3 KEY PLAYERS ............................................................... 140

6.4 MENTAL AND NEUROLOGICAL DISORDERS ............................. 141

6.4.1 DEVICES ...................................................................... 143

6.4.2 APPS ............................................................................ 144

6.4.3 KEY PLAYERS ............................................................... 144

6.5 FITNESS & LIFESTYLE THERAPEUTICS .................................... 144

6.5.1 DEVICES ...................................................................... 147

6.5.2 APPS ............................................................................ 147

6.5.3 KEY PLAYERS ............................................................... 147

6.6 OTHERS .................................................................................. 148

7 GLOBAL MHEALTHMARKET – APPLICATION/ SOLUTION TYPE ........150

7.1 INTRODUCTION ...................................................................... 150

7.1.1 MONITORING APPLICATIONS ...................................... 152

7.1.1.1 Key Participants ...................................................... 157

7.1.2 DIAGNOSIS & TREATMENT ........................................... 157


7.1.3 EDUCATION AND AWARENESS ..................................... 164


7.1.4 HEALTHCARE MANAGEMENT ......................................... 169

7.1.5 WELLNESS & PREVENTION ........................................... 174

7.1.6 OTHERS/ OTHER SERVICES AND APPLICATIONS MARKET ....................................................................... 178

7.1.7 REMOTE DATA COLLECTION ......................................... 181

BIS Research Sample



7.1.7.1 Key Market Developments ........................................ 182

8 GLOBAL MHEALTH MARKET–GEOGRAPHY ..............................................184

8.1 INTRODUCTION ...................................................................... 184

8.1.1 MARKET STATISTICS .................................................... 185

8.1.2 THE AMERICAS ............................................................. 186

8.1.3 NORTH AMERICA .......................................................... 189

8.1.3.1 The U.S.................................................................. 189

8.1.3.1.1 Key Market trends, Developments and

Participants ................................................... 190

8.1.3.1.1.1 Key Market Trends and Developments ............... 190


8.1.3.2 Canada .................................................................. 191

8.1.3.2.1 Key Market Trend ........................................... 192

8.1.3.2.2 Key players ................................................... 192

8.1.3.3 South America ........................................................ 192

8.1.3.3.1 Constraints ................................................... 192

8.1.3.3.2 Key Market Trends, Developments and Participants ................................................... 193



8.1.4 ASIA-PACIFIC (APAC) .................................................. 194

8.1.4.1 Key Drivers in APAC ................................................. 197


8.1.4.1.1.1 Market Trends & Development .......................... 198


8.1.4.2 CHINA ................................................................... 200

8.1.4.3 JAPAN .................................................................... 200

8.1.4.4 AUSTRALIA ............................................................. 201

8.1.4.5 INDIA .................................................................... 201

8.1.5 EUROPE ....................................................................... 202


8.1.5.2 The U.K. ................................................................ 206

8.1.5.3 Germany ................................................................ 206


BIS Research Sample



8.1.6 REST OF THE WORLD (ROW) ........................................ 207

8.1.6.1 Africa ..................................................................... 210




8.1.7 MIDDLE EAST ............................................................... 211




9 KEY MARKET DEVELOPMENT AND STRATEGIES ....................................213

9.1 INTRODUCTION ...................................................................... 213

9.1.1 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS ....................................................... 214

9.1.2 MERGERS & ACQUISITIONS ......................................... 216

9.1.3 PRODUCT DEVELOPMENT AND LAUNCH ........................ 217

9.1.4 BUSINESS EXPANSION/CONTRACTS ............................ 219

9.1.5 PATENTS, APPROVALS AND CERTIFICATIONS .............. 221

9.1.6 OTHERS (EVENTS & RECOGNITIONS) ........................... 222

10 COMPANY PROFILES .........................................................................................224

1.1 AGAMATRIX, INC. ................................................................... 224

10.1.1 OVERVIEW ................................................................... 224

10.1.2 FINANCIALS................................................................. 224

10.1.3 KEY DEVELOPMENTS .................................................... 225

10.2 ALIVECOR, INC. ...................................................................... 226

10.2.1 OVERVIEW ................................................................... 226

10.2.2 FINANCIALS................................................................. 226


10.3 APPLE, INC. ............................................................................ 230

10.3.1 OVERVIEW ................................................................... 230

10.3.2 FINANCIALS................................................................. 231

10.3.2.1 Overall Financials .................................................... 231

10.3.2.2 Financials By Segment ............................................. 232

10.3.2.3 Financials By Region ................................................ 233

BIS Research Sample



10.3.2.4 Financial Summary .................................................. 233

10.3.3 KEY DEVELOPMENT ...................................................... 234

10.4 ATHENAHEALTH INC. .............................................................. 235

10.4.1 OVERVIEW ................................................................... 235

10.4.2 FINANCIALS................................................................. 236


10.4.2.2 Financial by Segments ............................................. 237


10.4.3 KEY DEVELOPMENT ...................................................... 238

10.5 AT&T, INC. .............................................................................. 240

10.5.1 OVERVIEW ................................................................... 240

10.5.2 FINANCIALS................................................................. 241





10.6 BIOTELEMETRY, INC. (CARDIONET) ....................................... 244

10.6.1 OVERVIEW ................................................................... 244

10.6.2 FINANCIALS................................................................. 245


10.6.2.2 Financials by Segment ............................................. 246



10.7 GE HEALTHCARE ..................................................................... 248

10.7.1 OVERVIEW ................................................................... 248

10.7.2 FINANCIALS................................................................. 249





10.8 GOOGLE INC. .......................................................................... 253

10.8.1 OVERVIEW ................................................................... 253

10.8.2 FINANCIALS................................................................. 254



BIS Research Sample



10.9 JAWBONE, INC. ....................................................................... 256

10.9.1 OVERVIEW ................................................................... 256

10.9.2 FINANCIALS................................................................. 256


10.10 JOHNSON & JOHNSON ............................................................ 258

10.10.1 OVERVIEW ................................................................... 258

10.10.2 FINANCIALS................................................................. 259


10.10.2.2 Net Revenue By Segment ......................................... 259

10.10.2.3 Net revenue by Region ............................................. 260


10.11 LABORATORY CORPORATION OF AMERICA HOLDINGS ........... 261

10.11.1 OVERVIEW ................................................................... 261

10.11.2 FINANCIALS................................................................. 262





10.12 MEDTRONIC PLC ..................................................................... 265

10.12.1 OVERVIEW ................................................................... 265

10.12.2 FINANCIALS................................................................. 266




10.13 NIKE INC. ............................................................................... 269

10.13.1 OVERVIEW ................................................................... 269

10.13.2 FINANCIALS................................................................. 270


10.13.2.2 Financials by Segments ............................................ 271



10.14 PFIZER .................................................................................... 272

10.14.1 OVERVIEW ................................................................... 272

10.14.2 FINANCIALS................................................................. 273


BIS Research Sample





10.14.2.4 FINANCIAL SUMMARY .............................................. 275


10.15 PHILIPS HEALTHCARE ............................................................ 276

10.15.1 OVERVIEW ................................................................... 276

10.15.2 FINANCIALS................................................................. 277






10.16 QUALCOMM, INC. .................................................................... 279

10.16.1 OVERVIEW ................................................................... 279

10.16.2 FINANCIALS................................................................. 280






10.17 QUEST DIAGNOSTICS INC. ..................................................... 284

10.17.1 OVERVIEW ................................................................... 284

10.17.2 FINANCIALS................................................................. 285





10.18 ROCHE HOLDING AG-BR ......................................................... 288

10.18.1 OVERVIEW ................................................................... 288

10.18.2 FINANCIALS................................................................. 289





10.19 SAMSUNG ELECTRONICS CO. LTD. .......................................... 291

BIS Research Sample



10.19.1 OVERVIEW ................................................................... 291

10.19.2 FINANCIALS................................................................. 293

10.19.2.1 Overall financials ..................................................... 293



10.20 SANOFI PHARMA .................................................................... 294

10.20.1 OVERVIEW ................................................................... 294

10.20.2 FINANCIALS................................................................. 295


10.20.3 FINANCIALS BY SEGMENT ............................................ 296

10.20.4 FINANCIAL SUMMARY .................................................. 296


10.21 WITHINGS SAS ....................................................................... 298

10.21.1 OVERVIEW ................................................................... 298

10.21.2 FINANCIALS................................................................. 299


BIS Research Sample



LIST OF TABLES

TABLE 1 LEADING COMPANIES IN THE MHEALTH MARKET 30

TABLE 2 SECURITY BREACHMENT CASES/ DEVELOPMENTS (2011-2015) 47

TABLE 3 MHEALTH INDUSTRY: KEY PARTNERSHIPS 51

TABLE 4 VALUE CHAIN: KEY PARTICIPANTS OFECOSYSTEM 57

TABLE 5 CONSORTIUMS IN MHEALTH MARKET 59

TABLE 6 ALLIANCE/ASSOCIATIONS IN MHEALTH MARKET 60

TABLE 7 REGULATORY BODIES IN MHEALTH MARKET 63

TABLE 8 MHEALTH MARKET CERTIFICATIONS 67

TABLE 9 FACTORS IMPACTING THE BUYER’S BARGAINING POWER 71

TABLE 10 FACTORS IMPACTING THE SUPPLIER’S BARGAINING POWER 72

TABLE 11 FACTORS IMPACTING THE THREAT FROM SUBSTITUTE 73

TABLE 12 FACTORS IMPACTING THE THREAT FROM NEW ENTRANT 73

TABLE 13 FACTORS IMPACTING THE DEGREE OF COMPETETION 74

TABLE 14 GLOBAL MHEALTH MARKET VALUE, BY ECOSYSTEM, 2014-2022

($MILLION) 76

TABLE 15 GLOBAL MHEALTH DEVICE MARKET VALUE, BY DEVICE TYPE, 2014-2022 ($MILLION) 79

TABLE 16 GLOBAL MHEALTH DEVICE MARKET VALUE, BY APPLICATION TYPE 2014-2022 ($MILLION) 81

TABLE 17 GLOBAL MHEALTH SERVICE MARKET VALUE, BY SERVICE TYPE, 2014-2022 ($MILLION) 108

TABLE 18 GLOBAL MHEALTHSERVICES MARKET VALUE, BY APPLICATION TYPE 2014-2022 ($MILLION) 109

TABLE 19 KEY DEVELOPMENTS 115

TABLE 20 NETWORK & SERVICES: KEY DEVELOPMENTS 119

TABLE 21 PHARMACEUTICALS SERVICE: KEY DEVELOPMENT 122

TABLE 22 GLOBAL MHEALTHMARKET VALUE, BY THERAPEUTICS, 2014-2022

($MILLION) 125

TABLE 23 CARDIOVASCULAR DISEASE: GLOBAL MHEALTHMARKET VALUE, BY

APPLICATION, 2014-2022 ($MILLION) 126

TABLE 24 CARDIOVASCULAR DISEASE: GLOBAL MHEALTHMARKET VALUE, BY GEOGRAPHY, 2014-2022 ($MILLION) 127

TABLE 25 TYPE OF APP 129


TABLE 27 DIABETES: GLOBAL MHEALTHMARKET VALUE, BY APPLICATION, 2014-2022 ($MILLION) 133

BIS Research Sample



TABLE 28 DIABETES: GLOBAL MHEALTHMARKET VALUE, BY GEOGRAPHY, 2014-2022 ($MILLION) 134


TABLE 30 RESPIRATORY DISEASE: GLOBAL MHEALTHMARKET VALUE, BY APPLICATION, 2014-2022 ($MILLION) 138

TABLE 31 RESPIRATORY DISEASE: GLOBAL MHEALTHMARKET VALUE, BY GEOGRAPHY, 2014-2022 ($MILLION) 139

TABLE 32 NEUROLOGY/ MENTAL HEALTH: GLOBAL MHEALTHMARKET VALUE, BY


TABLE 33 NEUROLOGY/ MENTAL HEALTH: GLOBAL MHEALTHMARKET VALUE, BY GEOGRAPHY, 2014-2022 ($MILLION) 142

TABLE 34 FITNESS & LIFESTYLE: GLOBAL MHEALTHMARKET VALUE, BY APPLICATION, 2014-2022 ($MILLION) 145

TABLE 35 FITNESS & LIFESTYLE: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2014-2022 ($MILLION) 146

TABLE 36 OTHER DISEASES: GLOBAL MHEALTH MARKET VALUE, BY


TABLE 37 OTHER DISEASES: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY,

2014-2022 ($MILLION) 149

TABLE 38 GLOBAL MHEALTH MARKET VALUE, BY APPLICATION, 2014-2022 ($MILLION) 151

TABLE 39 MONITORING APPLICATIONS: GLOBAL MHEALTH MARKET VALUE, BY ECOSYSTEM, 2014-2022 ($MILLION) 152

TABLE 40 MONITORING APPLICATIONS: GLOBAL MHEALTH MARKET VALUE, BY THERAPEUTICS, 2014-2022 ($MILLION) 153

TABLE 41 MONITORING APPLICATIONS: GLOBAL MHEALTH MARKET VALUE, BY

GEOGRAPHY, 2014-2022 ($MILLION) 154

TABLE 42 REMOTE MONITORING IN GEOGRAPHIES 156

TABLE 43 DIAGNOSIS & TREATMENTS: GLOBAL MHEALTH MARKET VALUE, BY ECOSYSTEM, 2014-2022 ($MILLION) 158

TABLE 44 DIAGNOSIS & TREATMENTS: GLOBAL MHEALTH MARKET VALUE, BY THERAPEUTICS, 2014-2022 ($MILLION) 159

TABLE 45 DIAGNOSIS & TREATMENTS: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2014-2022 ($MILLION) 160

TABLE 46 DIAGNOSIS AND TREATMENT IN GEOGRAPHIES 162

TABLE 47 EDUCATION & AWARENESSS: GLOBAL MHEALTH MARKET VALUE, BY ECOSYSTEM, 2014-2022 ($MILLION) 164

TABLE 48 EDUCATION & AWARENESSS: GLOBAL MHEALTH MARKET VALUE, BY

THERAPEUTICS, 2014-2022 ($MILLION) 165

TABLE 49 EDUCATION & AWARENESSS: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2014-2022 ($MILLION) 166

TABLE 50 EDUCATION & WELLNESS IN GEOGRAPHIES 167

BIS Research Sample



TABLE 51 HEALTHCARE MANAGEMENTS: GLOBAL MHEALTH MARKET VALUE, BY ECOSYSTEM, 2014-2022 ($MILLION) 170

TABLE 52 HEALTHCARE MANAGEMENTS: GLOBAL MHEALTH MARKET VALUE, BY THERAPEUTICS, 2014-2022 ($MILLION) 171

TABLE 53 HEALTHCARE MANAGEMENTS: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2014-2022 ($MILLION) 172

TABLE 54 HEALTHCARE MANAGEMENT IN GEOGRAPHIES 173

TABLE 55 WELLNESS & PREVENTIONS: GLOBAL MHEALTH MARKET VALUE, BY

ECOSYSTEM, 2014-2022 ($MILLION) 174

TABLE 56 WELLNESS & PREVENTIONS: GLOBAL MHEALTH MARKET VALUE, BY THERAPEUTICS, 2014-2022 ($MILLION) 175

TABLE 57 WELLNESS & PREVENTIONS: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2014-2022 ($MILLION) 176

TABLE 58 WELLNESS & PREVENTION APPLLICATIONS IN DIFFERENT GEOGRAPHIES 177

TABLE 59 OTHERS APPLICATIONSS: GLOBAL MHEALTH MARKET VALUE, BY

ECOSYSTEM, 2014-2022 ($MILLION) 178

TABLE 60 OTHERS APPLICATIONS: GLOBAL MHEALTH MARKET VALUE, BY

THERAPEUTICS, 2014-2022 ($MILLION) 179

TABLE 61 OTHERS APPLICATIONSS: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2014-2022 ($MILLION) 180

TABLE 62 MHEALTH: KEY DEVELOPMENTS (2011- 2015) 182

TABLE 63 GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2014-2022 ($MILLION) 185

TABLE 64 THE AMERICAS: MHEALTH MARKET VALUE, BY REGIONS, 2014-2022 ($MILLION) 186

TABLE 65 THE AMERICAS: MHEALTH MARKET VALUE, BY THERAPEUTICS, 2014-

2022 ($MILLION) 187

TABLE 66 THE AMERICAS: MHEALTH MARKET VALUE, BY APPLICATION, 2014-2022 ($MILLION) 188

TABLE 67 THE U.S.: KEY DEVELOPMENTS 191

TABLE 68 SOUTH AMERICA: MHEALTH MARKET DEVELOPMENT (2011-2015) 193

TABLE 69 APAC: MHEALTH MARKET VALUE, BY THERAPEUTICS, 2014-2022 ($MILLION) 194

TABLE 70 APAC: MHEALTH MARKET VALUE, BY APPLICATION, 2014-2022 ($MILLION) 195

TABLE 71 KEY DEVELOPMENTS IN APAC 198

TABLE 72 EUROPE: MHEALTH MARKET VALUE, BY THERAPEUTICS, 2014-2022 ($MILLION) 202

TABLE 73 EUROPE: MHEALTH MARKET VALUE, BY APPLICATION, 2014-2022

($MILLION) 203

TABLE 74 EUROPE: MHEALTH MARKET DEVELOPMENT 205

BIS Research Sample



TABLE 75 ROW: MHEALTH MARKET VALUE, BY REGIONS, 2014-2022 ($MILLION) 207

TABLE 76 ROW: MHEALTH MARKET VALUE, BY THERAPEUTICS, 2014-2022 ($MILLION) 208

TABLE 77 ROW: MHEALTH MARKET VALUE, BY APPLICATION, 2014-2022 ($MILLION) 209

TABLE 78 AFRICA: MHEALTH MARKET DEVELOPMENTS(2011-2014) 210

TABLE 79 MIDDLE EAST: MHEALTH MARKET DEVELOPMENTS (2014-2011) 212

BIS Research Sample



LIST OF FIGURES

FIGURE 1 MHEALTH MARKET STUDY: COVERAGE AREA 21

FIGURE 2 BIS RESEARCH METHODOLOGY 23

FIGURE 3 DIFFERENT PHASES OF RESEARCH METHODOLOGY FOR THE GLOBAL MARKET 24

FIGURE 4 MHEALTH MARKET: RESEARCH METHODOLOGY 26

FIGURE 5 GLOBAL MHEALTH MARKET, BY ECOSYSTEM, 2014-2022 ($MILLION) 32

FIGURE 6 GLOBAL MHEALTH MARKET, BY THERAPEUTICS, 2014-2022 ($MILLION) 33

FIGURE 7 GLOBAL MHEALTH MARKET, BY APPLICATION, 2014-2022 ($MILLION) 34

FIGURE 8 GLOBAL MHEALTH MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION) 35

FIGURE 9 MARKET DRIVERS AND CHALLENGES 37

FIGURE 10 MHEALTH MARKET DRIVERS: IMPACT ANALYSIS 38

FIGURE 11 BENEFITS OF MHEALTH TO PATIENTS 39

FIGURE 12 EXAMPLES OF EXISTING MHEALTH INNOVATIONS 42

FIGURE 13 MHEALTH MARKET CHALLENGES: IMPACT ANALYSIS 45

FIGURE 14 MAJOR BARRIERS CAUSED BY REGULATION AND STANDARDS 49

FIGURE 15 VALUE CHAIN 54

FIGURE 16 ROLES AND RESPONSIBILITIES OF HEALTHCARE POLICY MAKERS 58

FIGURE 17 CLASSIFICATION OF MEDICAL DEVICES 66

FIGURE 18 MHEALTH MARKET: PORTER FIVE FORCE ANALYSIS 70

FIGURE 19 MHEALTH ECOSYSTEM 77

FIGURE 20 TYPE OF MHEALTH DEVICES 79

FIGURE 21 SMBD DEVICE USES 83

FIGURE 22 USES OF BP MONITORING DEVICE 86

FIGURE 23 PULSE OXIMETER USES 87

FIGURE 24 WEARABLE DEVICE COMPONENTS 90

FIGURE 25 TYPE OF WEARABLE ELECTRONICS DEVICES 90

FIGURE 26 HAND WORN MHEALTH DEVICES 91

FIGURE 27 APPLE WATCH FIGURE 92

FIGURE 28 LEADING FITNESS TRACKING WRIST BANDS 93

FIGURE 29 GOOGLE’S CONTACT LENS 94

FIGURE 30 HEAD WORN DEVICES 94

FIGURE 31 ELECTRONIC FINGERTIP 96

FIGURE 32 COMPONENTS OF BIOSTAMP 98

BIS Research Sample



FIGURE 33 MYO ARMBAND BY THALMIC LABS 99

FIGURE 34 NON-CLINICAL BENEFITS 100

FIGURE 35 WEARABLE MEDICAL DEVICES 101

FIGURE 36 FITNESS TRACKING DEVICES 103

FIGURE 37 TYPES OF MHEALTH SERVICES 107

FIGURE 38 TYPES OF APPS 111

FIGURE 39 BENEFITS OF BIG DATA 114

FIGURE 40 BENEFITS OF NETWORK & SERVICES 117

FIGURE 41 ROLES OF MOBILE OPERATORS 118

FIGURE 42 ROLE OF HEALTHCARE PROVIDERS 121

FIGURE 43 MHEALTH: MARKET BY THERAPEUTICS 124

FIGURE 44 BENEFITS OF MHEALTH IN CVDS 128

FIGURE 45 BENEFITS OF MHEALTH 135




FIGURE 49 TYPES OF MHEALTH APPLICATION 150

FIGURE 50 ADVANTAGES OF REMOTE MONITORING 155

FIGURE 51 DIAGNOSIS AND TREATMENT SERVICES 161

FIGURE 52 EDUCATION & AWARENESS SERVICES 167

FIGURE 53 MHEALTH HEALTHCARE MANAGEMENT 169

FIGURE 54 GLOBAL MHEALTH MARKET CLASSIFICATION, BY GEOGRAPHY 184

FIGURE 55 APAC: MARKET DRIVERS 197

FIGURE 56 MHEALTH: PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS

(2015) 214

FIGURE 57 MHEALTH: MERGERS & ACQUISITIONS(2015) 216

FIGURE 58 MHEALTH: KEY PRODUCT LAUNCH & DEVELOPMENTS (2015) 218

FIGURE 59 MHEALTH: KEY BUSINESS EXPANSIONS & CONTRACTS (2015) 220

FIGURE 60 MHEALTH: KEY PATENTS/APPROVALS( 2015) 222

FIGURE 61 APPLE INC. OVERALL FINANCIALS ($BILLION), 2012-2014 231

FIGURE 62 APPLE INC.: NET REVENUE, BY SEGMENT, 2012-2014 232

FIGURE 63 APPLE INC.: NET REVENUE, BY REGION, 2012-2014 233

FIGURE 64 ATHENAHEALTH: OVERALL FINANCIALS, 2012-2014 ($MILLION) 236

FIGURE 65 ATHENAHEALTH: NET REVENUE, BY SEGMENT, 2012-2014 ($MILLION) 237

FIGURE 66 AT&T INC.: OVERALL FINANCIALS ($BILLION), 2012-2014 241

FIGURE 67 AT&T INC.: NET REVENUE BY SEGMENT, 2012-2014 242

FIGURE 68 BIOTELEMETRY INC.: OVERALL FINANCIALS ($BILLION), 2012-2014 245

BIS Research Sample



FIGURE 69 BIOTELEMETRY INC.: NET REVENUE BY SEGMENTS ($MILLION), 2012-2014 246

FIGURE 70 GE CORPORATION: OVERALL FINANCIALS ($MILLION), 2012-2014 249

FIGURE 71 GE ELECTRONIC: NET REVENUE BY SEGMENTS ($MILLION), 2012-2014 250

FIGURE 72 GE HEALTHCARE SEGMENT, 2014 250

FIGURE 73 GOOGLE: OVERALL FINANCIALS, 2012 - 2014 ($BILLION) 254

FIGURE 74 J&J: OVERALL FINANCIALS, 2012 - 2014 ($ BILLION) 259

FIGURE 75 LABCORP OVERALL FINANCIALS ($MILLION), 2012-2014 262

FIGURE 76 NET REVENUE BY SEGMENTS, 2012-2014 263

FIGURE 77 NIKE: OVERALL FINANCIALS 2012 - 2014 ($BILLION) 270

FIGURE 78 NIKE: REVENUE BY REGION (2012-2013) 271

FIGURE 79 PFIZER: OVERALL FINANCIALS, 2012-2014 ($BILLION) 273

FIGURE 80 PFIZER: FINANCIALS BY SEGMENT, 2012-2014 ($MILLION) 274

FIGURE 81 PFIZER: FINANCIALS BY REGION, 2012-2013 ($BILLION) 274

FIGURE 82 PHILIPS: OVERALL FINANCIALS, 2012-2014 ($MILLION) 277

FIGURE 83 PHILIPS: FINANCIALS BY REGION, 2012-2014 ($MILLION) 278

FIGURE 84 PHILIPS: FINANCIALS BY SEGMENT, 2012-2014 ($MILLION) 278

FIGURE 85 QUALCOMM INC.: OVERALL FINANCIALS, 2012-2014 ($BILLION) 280

FIGURE 86 QUALCOMM INC.: NET REVENUE, BY SEGMENT, 2012-2014 ($MILLION) 281

FIGURE 87 QUALCOMM INC.: NET REVENUE, BY REGION, 2012-2014 ($MILLION) 281

FIGURE 88 QUEST: OVERALL FINANCIALS, 2012-2014 ($MILLION) 285

FIGURE 89 QUEST: NET REVENUE BY SEGMENTS, 2013-2014 ($MILLION) 286

FIGURE 90 ROCHE: OVERALL FINANCIALS, 2012-2014 ($BILLION) 289

FIGURE 91 ROCHE: NET REVENUE, BY SEGMENTS, 2012-2014 ($BILLION) 290

FIGURE 92 SAMSUNG ELECTRONICS CO. LTD.: OVERALL FINANCIALS ($BILLION), 2012-2014 293

FIGURE 93 SANOFI PHARMA: OVERALL FINANCIALS ($BILLION), 2012-2014 295

FIGURE 94 SANOFI PHARMA: NET REVENUE BY SEGMENT, 2012-2014 296

BIS Research Sample



LIST OF ACRONYMS

Acronyms Descriptions

ABC About Building Connections

APAC Asia-Pacific

APIs Application Program Interfaces

ATA American Telemedicine Association

BGM Blood Glucose Monitoring

BIDMC Beth Israel Deaconess Medical Center

BP Blood Pressure

CHF Congestive Heart Failure

CIA Central Intelligence Agency

CIHR Canadian Institutes of Health Research

EBRD European Bank for Reconstruction and Development

ECG Electrocardiogram

e-health electronic health

EHR Electronic Health Records

FCC Federal communications commission

FDA Food and Drug Administration

FDA Food and Drug Administration

GDP Gross Domestic Product

GHTF Global Harmonization Task Force on Medical Devices

GMTA Global Medical Technology Alliance

GSMA Groupe Speciale Mobile Association

BIS Research Sample




HIPAA Health Insurance Portability and Accountability Act

HIPAA Health Insurance Portability and Accountability Act

HMD Head Mounted Display

HUD Head Up Display

ICT Information and communications technology

ITU International Telecommunication Union

IVR Interactive Voice Response

LMICs Low- And Middle-Income Countries

MMA Medical Mobile Application

MRS Medical Record System

ODK Open Data Kit

OECD Organization for Economic Co-Operation and Development

OEM original equipment manufacturers

OTC Over-The-Counter

PCORI Patient-Centered Outcomes Research Institute

PDAs personal digital assistant

PESTLE Political, Economical, Social, Technological and Economical

PLGM Predictive Low Glucose Management

PPP purchasing power parity

ROW Rest Of The World

U.K. United Kingdom

U.S.A. United States of America

UCSF University of California at San Francisco

USAID United States Agency for International Development

BIS Research Sample




WHO World Health Organization

WHUSA Women Health USA

WLSA Wireless-Life Science Alliance’s

WLSA Wireless-Life Sciences Alliance

BIS Research Sample



1 REPORT SCOPE

1.1 SCOPE OF THE STUDY

The scope of this report is limited to the a detailed study of the Mobile Health (mHealth)

devices and services in the market. The study includes an analysis of therapeutics and

applicationsin which mHealth is used, in addition to the market study of the mHealth devices

and services used across different geographical regions. The study presents a detailed analysis

of the mHealth ecosystem (devices and services), therapeutics, applications, and geography

along these lines: market size, drivers, growth opportunities, and challenges. The major end-

use application areas of mHealth devices and services with respect to the market size and

growth rate has also been identified and discussed in the report.

1.1.1 MOBILE HEALTH (MHEALTH): REPORT COVERAGE

The figure below shows the list of market coverage features which are incorporated in this

research study.

FIGURE 1

MHEALTH MARKET STUDY: COVERAGE AREA

Global mHealth Market Coverage

Ecosystem Therapeutics Type Application Type

mHealth Devices

mHealth Services

Cardiovascular

Respiratory

Diabetes

Neurology/ Mental Health

Fitness & Lifestyle

Remote Monitoring

Diagnosis and Treatment

Others

Education and Awareness

Healthcare Management

Prevention & Wellness

Geography

The Americas

Europe

APAC

Rest of the World (RoW)

Source: BIS Research Analysis

BIS Research Sample



1.1.2 GLOBAL MOBILE HEALTH (MHEALTH): RESEARCH METHODOLOGY

The following illustrative figure shows the market research methodology applied in preparing

this report on the mHealth market.

FIGURE 2

MHEALTH MARKET: RESEARCH METHODOLOGY

Secondary

Research

Value Chain

Key Players

End-user Applications

Market Classif ication

Annual Reports of Key Industry Players

Geographical Markets with their Market Shares

Market Trends

Technological Developments

Primary Research

Numbers Validation

Competitive Landscape Validation

Market Dynamics Validation

Market Crackdown

Top-Down Approach

Bottom-Up Approach

Data Triangulation

Qualitative & Quantitative Analysis

Market Segmentation

Market Estimates

Market Forecasts


1.1.3 REPORT DESCRIPTION

The dynamic nature of the regulatory compliances in the healthcare industry and the reduced

risk factors are pushing the acceptance of mHealth solutions across varied end-user segments.

BIS Research Sample



As a disease’s diagnosis, treatment, monitoring and other services can be managed remotely

around the world; mHealth market is gaining traction and is expected to grow at a double digit

CAGR through 2015 to 2022

The growing popularity of wearable devices pertaining to medical applications is further

propelling the demand of mHealth solutions across the ecosystem. In Mobile Health (mHealth)

services, mobile communications such as personal digital assistant (PDAs), laptops, and mobile

phones among others, are used for providing health information and services. mHealth enables

various electronic health (e-health) data content and services to users, by using wireless

technologies such as WiMax, Bluetooth, GSM/GPRS/3G, and WiFi among others. These data

contents and services are accessed by the health providers, consumers (patients) and other

related users through devices such as mobile phones, smart phones, PDAs, laptops and tablet

PCs (personal computers).

The mHealth market report presents detailed analysis of the entire mHealth ecosystem and

provides extensive insights of the different mHealth devices and services providers. The report

also focuses on different applications in which mHealth solutions are being used. Further, the

scope of the report includes the therapeutics of different disease types managed by mHealth

devices and services. All of the above mentioned report coverage parametersarediscussed

across different regions like The Americas, Europe, Asia Pacific (APAC) and Rest of the World

(RoW).

While highlighting the key driving and restraining forces for this dynamic market, the report

also provides a comprehensive section of the prominent consortiums, compliance, and

regulatory bodies and their involvement in the mobile health (mHealth) market.

The answers to the following key questions can be found in the report:

What are the major market drivers, challenges and opportunities of the mHealth

market and their use cases?

Which factors will be driving the market through the forecast period?

What factors are currently challenging the mHealth industry?

What are the use cases and key platforms to deliver the services of each application?

BIS Research Sample



What are the key developmental strategies in different applications across all

regions?

How will the key market players leverage on key developments such as Mergers and

Acquisitions, Partnerships, and Product Launch among others?

Which compliances and certifications are necessary to make a product acceptable?

Which geographical region will lead the global mHealth market by the end of the

forecast period?

Who are the key players in the mHealth market?

The research tries to answer various aspects of the mHealth market such as factors driving the

market, its threats that can possibly slow down the market growth and the current growth

opportunities that are going to shape the market expansion of mHealth solutions (devices and

services). The research incorporates Porter’s Five Force Model for in-depth analysis of the

mHealth device market and an assessment of the factors governing it. The report builds itself

upon a comprehensive value chain giving a clear understanding of ecosystem of mHealth

market penetration.

Our study includes an overview and analysis of the mHealth market by ecosystem,

applications, therapeutics and geographical regions, allowing the research to develop a

comprehensive outlook of the market. The report includes the profiles of major players in the

mHealth ecosystem that allows its reader to get an insight into the industry trends.

Towards the end of the report, readers will have a clear understanding of the market

dynamics, its major drivers and the underlying threats and challenges of the global mHealth

market.

Some of the leading companies in the mHealth market are listed below:-

TABLE 1

LEADING COMPANIES IN THE MHEALTH MARKET

BIS Research Sample



S.No. Company Name

1 AgAmatrix, Inc.

2 AliveCor, Inc.

3 APPLE, Inc.

4 AT&T, Inc.

5 AthenaHealth Inc.

6 BioTelemetry, Inc. (Cardionet)

7 GE Healthcare

8 Google inc.

9 Jawbone, Inc.

10 Johnson & Johnson

11 Laboratory Corporation Of America Holdings

12 Medtronic PLC

13 NIKE INC.

14 Pfizer

15 Philips Healthcare

16 Qualcomm, Inc.

17 Quest Diagnostics Inc

18 Roche Holding AG-Br

19 Samsung electronics Co. LTD.

20 Sanofi

21 WITHINGS SAS

BIS Research Sample



2 EXECUTIVE SUMMARY

Mobile Health refers to using mobile communications, such as personal digital assistant

(PDAs), laptops, and mobile phones for health services and related information.

On the basis of ecosystem, the global mHealth market is classified into devices and services.

Device segment includes medical devices, health & fitness devices and home care devices

among others. Moreover, the service segment is further fragmented into mobile apps &

content solution developers, network/Mobile operators and healthcare & pharmaceuticals.

FIGURE 3

GLOBAL MHEALTH MARKET, BY ECOSYSTEM, 2014-2022 ($MILLION)

XX

XX

XX

XX

XX

XX

XX

2014 2015 2016 2017 2018 2019 2020 2021 2022

$M

illi

on

mHealth devices mHealth Services

Source: ME-BIS Research

The mHealth services dominated the market in 2014 and is expected to grow over $XX billion

by the end of the forecast period due to the increasing usage of mHealth solutions by

healthcare providers and pharmaceutical companies along with end users (patients). In

addition to this, different service providers are entering into partnerships with other ecosystem

players to enhance the development of mHealth solutions. However, device segment is

BIS Research Sample



expected to grow in near future with a high CAGR of XX%, from 2015 to 2022, due to

increasing integration of mHealth devices with smart phones and weareables, and also,

increasing opportunities of connected health solutions are predicted to promote the growth of

this market through the forecast period.

The global mHealth market on the basis of therapeutics is classified as cardiovascular,

diabetes, respiratory, neurology/mental health, fitness & lifestyle and other diseases. At

present, diabetes is dominating in the market and is expected to reach $XX billion by 2022, as

the number of diabetic patients are increasing every year and thus, deployment of monitoring

and diagnosis applications of diabetes is also anticipated to increase tremendously. A large

number of diabetes apps have been developed in the recent years that provide information,

diet charts, blood glucose level data, and education among other services. Regardless of this

fact, the cardiovascular therapeutic segment is estimated to grow at CAGR of XX% from 2015

to 2022.

FIGURE 4

GLOBAL MHEALTH MARKET, BY THERAPEUTICS,

2014-2022 ($MILLION)

XX

XX

XX

XX

XX

XX

2014 2015 2016 2017 2018 2019 2020 2021 2022

Cardiovascular Diabetes Respiratory Neurology/ Mental Health Fitness & Lifestyle Others


The primarily reason attributed to the growth of the mHealth therapeutics market is due to the

increasein cardiac diseases, hypertension, high/low blood pressures, and other heart related

BIS Research Sample



issues. The patients are more concerned about this these diseases as theycan be effectively

controlled at its primary stages and help them in emergency cases.

The global mhealth market, on the basis of these applications, is segmented into: monitoring,

diagnosis & treatment, education & awareness, healthcare management, prevention &

wellness and others. The monitoring application is acquiring a major share of the market and is

expected to grow over $XX billion by the end of forecast period.

FIGURE 5

GLOBAL MHEALTH MARKET, BY APPLICATION,

2014-2022 ($MILLION)

XX

XX

XX

XX

XX

XX

XX

2014 2015 2016 2017 2018 2019 2020 2021 2022

Monitoring Applications Diagnosis & Treatment Education & Awareness

Healthcare Management Wellness & Prevention Others


Most of the applications are deployed in monitoring of patients, post-acute care, maternal

health, and communicable diseases among others. However, education & awareness

application is foreseen to have high potential growth by the end of 2022 and is predicted to

grow at a CAGR of XX% during the forecast period. The increase in this application is due to

the growing involvement and concern of people regarding their personal health and it also

BIS Research Sample



includes an increase in telecommunication and wireless technologies that enables users to

grasp information easily.

The Americas has been the largest contributor to the net revenue in the global mHealth market

and is expected to grow over $XX billion by 2022. One of the main reasons for this dominance

is the advancement of internet and communication technologies in the developed countries of

America in comparison to other regions.

FIGURE 6

GLOBAL MHEALTH MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)

XX

XX

XX

XX

XX

XX

2014 2015 2016 2017 2018 2019 2020 2021 2022

The Americas Europe Asia-Pacif ic (APAC) RoW


However, the Rest Of the World (ROW) that majorly includes the African region and some

parts of the Middle Eastern region is poised to grow at the highest CAGR of XX% from 2015 to

2022. This is due to the increasing adoption of mHealth solutions because of aspects such as

low costs and the sheer convenience; and also because of availability of lesser number of

healthcare workers and practitioners over a large number of population.

BIS Research Sample



3 MARKET OVERVIEW

3.1 INTRODUCTION

Mobile health (mHealth) is one of the most modernized trends in the healthcare industry, that

has shown tremendous progress in the last few years. This trend is observed due to the

flourishing growth of personal health devices, which can be easily worn or used with a

smartphone or tablet. Mobile Health refers to the use of mobile communications, such as

personal digital assistant (PDAs), laptops, and mobile phones among others, for health

services and information. mHealth is a process of enabling various e-health data content and

services to users, by using wireless technologies such as WiMax, Bluetooth, GSM/GPRS/3G,

and WiFi among others. These data contents and services are accessed by the health

providers, consumers (patients), and other related users through devices such as mobile

phones, smart phones, PDAs, laptops, and tablet PCs (personal computers).

3.2 MARKET DYNAMICS

The global mHealth market has been identified as one of the fastest growing industries, owing

to the changing dynamics of the legal and regulatory framework and the intense competitive

rivalry among a plethora of public companies.

BIS Research Sample



FIGURE 7

MARKET DRIVERS AND CHALLENGES

Literacy and language barriers in low and middle-income countries (LMICs)

Invasion of Privacy

Potential risk of Hardware or Software failure

Stringent Regulations and Standards

Lack of Awareness about the possible applications of mHealth

CHALLENGES

Patients Involvement in personal healthcare

Penetration of smartphones and wearable devices into

healthcare

Integration of wireless technologies with portable healthcare devices

Benefits of Cost effectiveness and Patients’ Convenience

Increase in Lifestyle Disease

DRIVERS


The following segment will discuss the key market driving and restraining / challenging forces,

including the impact analysis for the same. Also, the opportunities have been identified and

discussed which can be used to the market player’s advantage to uplift their market position in

the growing industry.

3.2.1 MARKET DRIVERS

Market drivers are defined as the forces and trends that enable the markets to develop and

grow.The most common market drivers in the mHealth market are: patient’s involvement in

personal healthcare, penetration of smartphones and wearable devices into healthcare

industry, integration of wireless technologies with portable healthcare devices, benefits of Cost

effectiveness and Patients’ convenience and Increase in lifestyle diseases.

BIS Research Sample



FIGURE 8

MHEALTH MARKET DRIVERS: IMPACT ANALYSIS

DRIVERS IMPACT

1 Involvement of patients into personal healthcare

2 Introduction of smartphones and wearable devices into healthcare

3 Integration of wireless technologies with portable healthcare devices

4 Benefits of Cost effectiveness and Patients’ Convenience

5 Increase in Lifestyle Disease

Low Mediocre Medium High Very High


BIS Research Sample



3.2.2 MARKET CHALLENGES

Market challenges are the factors which are slowing down the growth of the market. These

factors challenge the market players from meeting the industry requirements and perform

ideally.

FIGURE 9

MHEALTH MARKET CHALLENGES: IMPACT ANALYSIS

CHALLENGES/ RESTRAINTS IMPACT

1 Low literacy and language barriers in low- and middle-income countries (LMICs)

2 Invasion of Privacy

3 Potential risk of Hardware or Software failure

4 Stringent Regulations and Standards

5 Lack of Awareness about the possible applications of m-Health

Low Mediocre Medium High Very High


BIS Research Sample



4 INDUSTRY DYNAMICS

4.1 VALUE CHAIN OF THE MHEALTH MARKET

The value chain analysis of the global mHealth market includes various stakeholders such as

device manufacturers, content providers, software developers, app developers, network

providers, and healthcare workers. They all are working in collaboration with one another to

achieve common goals i.e. providing customized services to patients for better standards of

wellness and fitness. The overall value chain of mHealth market is regulated by government

compliances and standards which are essential for this industry as it is directly related to

human beings health and fitness.

FIGURE 10

VALUE CHAIN


BIS Research Sample



TABLE 2

VALUE CHAIN: KEY PARTICIPANTS OFECOSYSTEM

Ecosystem players Key Players

Device Manufacturers Alive cor, Agamatrix, Fitbit, Withings, GE Healthcare,

Jawbone, and Medtronic among others

App Developer Samsung, Apple, IBM, Google Inc., iBigStar,

andAthenaHealth among others

Network / Mobile Operators AT&T, T-mobile, Vodafone, China Mobile

Healthcare provider &

Pharmaceuticals

Roche, Abbott, Quest Diagnostics, Pfizer, Bayer and GSK

among others


BIS Research Sample



FIGURE 11

MHEALTH MARKET: PORTER FIVE FORCE ANALYSIS

MEDIUM TO HIGH

Degree of Competition

MEDIUM

Threat from Substitutes

MEDIUM

Buyer's Power

MEDIUM

Supplier 's Power

LOW TO MEDIUM

Threat from New

Entrants


4.1.1 BARGAINING POWER OF BUYER

The bargaining power of the buyer is considered to have a “medium” impact on the industry.

The factors affecting the industry are discussed in the table below:-

BIS Research Sample



TABLE 3

FACTORS IMPACTING THE BUYER’S BARGAINING POWER

Factors Impact

Industry concentration Medium

Threat of backward integration Low

Buyer information about supplier product Medium

Switching cost Medium

Present of substitutes High


The bargaining power of the buyers assesses how easy it is for the buyers to have an effect on

the prices of the mHealth solutions. The power of buyers is the impact that customers have on

a producing industry. The bargaining power of the buyer is medium as the industry

concentration is also levelled at medium, butthe threat of backward integration is

low.However, the buyer’s information about supplier product is medium, the switching cost is

medium,whereas the present of substitutes is high.

4.1.2 BARGAINING POWER OF SUPPLIER

The industry impact of the supplier’s Bargaining Power is considered to have a “medium” level

impact.

BIS Research Sample



5 GLOBAL MHEALTH MARKET ECOSYSTEM

5.1 INTRODUCTION

The complexities of the mHealth ecosystem is due to a wide variety of stakeholders and

players in the global mHealth market. This ecosystem includes component providers of original

equipment (sensors, mobile phones, and Personal Digital Assistant (PDAs), medical device

manufacturers, healthcare providers, pharmaceutical companies, content developers, and

mobile operators. The global mHealth market accounted for $XX billion in 2014, dominated by

the mobile operator segment. This estimate does not include the expenditure on smartphones,

tablets and other ordinary mobile phones.

TABLE 4

GLOBAL MHEALTH MARKET VALUE, BY ECOSYSTEM,

2014-2022 ($MILLION)

Ecosystem 2014 2015 2017 2019 2021 2022

CAGR%

(2015-

2022)

mHealth devices

XX XX XX XX XX XX XX

mHealth Services


Total XX XX XX XX XX XX XX


BIS Research Sample



6 GLOBAL MHEALTHMARKET – THERAPEUTICS

6.1 INTRODUCTION

The mHealth solutions are effectively involved in curing many chronic and lifestyle diseases

such as diabetes, sleep apnea, obesity, hypertension and cardiac diseases among others. With

developments and innovations in wireless and mobile communication technology, m-Health is

considered to be the most efficient and effective way for both patients and healthcare workers.

These solutions are helping patients to personalize their healthcare options and also facilitating

physicians and clinicians to monitor the physiological factors in real time and accordingly

provide feedback to the patients.

FIGURE 12

MHEALTH: MARKET BY THERAPEUTICS

Global mHealth Therapeutics Market

Cardiovascular

Diabetes

Respiratory



The subsequent sections the devices, applications, key developments, use cases and key

players of each therapeutic type. It also mentions the benefits of mHealth in each section when

and wherever required.

BIS Research Sample



6.1.1 GLOBAL MARKET STATISTICS

TABLE 5

GLOBAL MHEALTHMARKET VALUE, BY THERAPEUTICS,

2014-2022 ($MILLION)

Disease

Type 2014 2015 2017 2019 2021 2022

CAGR%

(2015-

2022)

Cardiovascular XX XX XX XX XX XX XX

Diabetes XX XX XX XX XX XX XX

Respiratory XX XX XX XX XX XX XX



Fitness &

Lifestyle XX XX XX XX XX XX XX

Others XX XX XX XX XX XX XX



The global mHealth market for therapeutics accounted for $XX billion in 2014 and is expected

to grow to $XX billion by 2022, at an estimated CAGR of XX% from 2015 to 2022. The

diabetes segment dominated the global market in 2014 and accounted for $XX billion. The

major reasons include development of more diagnosis and monitoring devices that are

portable and technologically advanced . However, cardiovascular will be the fastest growing

therapeutic segment followed by respiratory and will be growing at a CAGR of XX% and XX%

respectively from 2015 to 2022.

BIS Research Sample



7 GLOBAL MHEALTHMARKET – APPLICATION/

SOLUTION TYPE

7.1 INTRODUCTION

The global mHealth market is further classified on the basis of applications for which the

mHealth solutions are being deployed. Large numbers of developing countries are using

mHealth solutions to address healthcare and fitness related problems. With the rapid increase

of smartphones and communication technologies in these regions, global mHealth applications

have been able to solve critical problems which arose due to poor infrastructure and

insufficient number of health-workers. Moreover, increasing demand for monitoring and

wellness applications including activity tracking, continuous glucose monitoring, heart rate

monitoring, and non-invasive drug delivery has surged forward the development of more

innovative products by big market players.

The global mHealth market is very dynamic and shows a wide range of applications that are

constantly escalating with the introduction of integrated smart devices. Applications of the

mHealth market are classified into the segments mentioned in the figure below:

FIGURE 13

TYPES OF MHEALTH APPLICATION

mHealth Application

Market

Monitoring Applications

Education And

Awareness

Education And

Awareness


Wellness & Prevention

Others Application


BIS Research Sample



The global mHealth market has been segmented into six parts that includes: monitoring,

diagnosis and treatment, education and awareness, healthcare management, prevention and

wellness and others.

TABLE 6

GLOBAL MHEALTH MARKET VALUE, BY APPLICATION,

2014-2022 ($MILLION)

Application

Type 2014 2015 2017 2019 2021 2022

CAGR%

(2015-

2022)

Monitoring Applications


Diagnosis & Treatment


Education &

Awareness XX XX XX XX XX XX XX



Wellness & Prevention


Others XX XX XX XX XX XX XX



The global mHealth market for application accounted for over $XX billion in 2014 and is

expected to grow at a CAGR of XX% from 2015 to 2022. Monitoring application of mHealth

dominated the global market in 2014 and accounted for $XX and it is due to increasing

deployment of mHealth solutions by healthcare providers and workers. This application helps

them to monitor the patient’s health and activity by using medical or weareable devices that

are connected with mHe

BIS Research Sample



8 GLOBAL MHEALTH MARKET–GEOGRAPHY

8.1 INTRODUCTION

The global mHealth market is segmented into four different regions namely; The Americas,

Europe, Asia-Pacific (APAC), and Rest of the World (ROW). We can also classify regions on the

basis of economic development that includes: untapped markets, emerging markets,

developing markets, and the developed markets. However, on the basis of opinion from

industry experts and various thought leaders, the report has been segmented into four

geographical regions which are as follows:

FIGURE 14

GLOBAL MHEALTH MARKET CLASSIFICATION, BY GEOGRAPHY


In the diagram, “The Americas” is a phrase technically used, but when you use the two

continents, its North AMERICA and South AMERICA. Not Americas.

This chapter further includes the key developments, market trends, and the market &

industrial dynamic factors of each region. This chapter also includes description of regulations

and compliances that are most important for mHealth market and also highlights key

participants of each region.

BIS Research Sample



8.1.1 MARKET STATISTICS

TABLE 7

GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY,

2014-2022 ($MILLION)

Region 2014 2015 2017 2019 2021 2022

CAGR%

(2015-

2022)

The Americas


Europe XX XX XX XX XX XX XX

Asia-Pacific (APAC)


RoW XX XX XX XX XX XX XX



The global mHealth market by geography accounted for over $XX billion in 2014 and is

expected to grow over$$XX billion by 2022. The Americas dominated the global market in

2014 with a share of $XX billion due to increasing adoption of mobile health solutions for

prevention and wellness. Following the Americas is APAC, where large number of

developments in mHealth have been noticed in the last few years. However, in ROW

specifically Africa is estimated to show highest growth with a CAGR of XX% from 2015 to

2022.

BIS Research Sample



9 COMPANY PROFILES

9.1 ATHENAHEALTH INC.

9.1.1 OVERVIEW

Particular Specifications (as of 2015)

Website www.athenahealth.com

Contact Details

311 Arsenal Street

Watertown, MA 02472

United States

Tel:617-402-1000

Fax: 617-402-1099

Year of Establishment 1997

Ownership Type Public

Company Type Service Provider

Number of Employees 3, 676

Subsidiaries

Epocrates Inc., Anodyne Health Partners, Inc., athena Point

Lookout, LLC, athenahealth MA, Inc., athenahealth Security

Corporation, athenahealth Technology Private Limited, and

Proxsys LLC among others

Competitors

GE Healthcare Ltd ., Allscripts Healthcare Solutions, Inc.,

ADP AdvancedMD Software, Inc., Epic Systems

Corporation, CareCloud Corporation, NextGen Healthcare

Information Systems, LLC, OptumInsight, Inc., Practice

Fusion, Inc., and SCI Solutions, Inc.

Related Product &Services

Electronic health records, revenue cycle management,

medical billing, patient engagement, care coordination, and

population health management

Source: AthenaHealth Website, BIS Research

BIS Research Sample



9.1.2 FINANCIALS

9.1.2.1 Overall F inancials

FIGURE 15

ATHENAHEALTH: OVERALL FINANCIALS, 2012-2014 ($MILLION)

2012 2013 2014

Net Revenue 422.3 595 752.6

Net Income 18.7 2.6 -3.1

Operating Income 29.5 11.00 1.00

-XX

XX

XX

XX

XX

XX

XX

XX

XX

XX

XX

XX

XX

XX

XX

XX

XX

XX

Ne

t In

com

e &

Op

era

tin

g In

com

e($

Mill

ion

)

Ne

t R

eve

nu

e($

Mill

ion

)

Source: AthenaHealth Annual Report, BIS Research

BIS Research Sample



9.1.2.2 Financial by Segments

FIGURE 16

ATHENAHEALTH: NET REVENUE, BY SEGMENT,

2012-2014 ($MILLION)

XX

XX

XX

XX

XX

XX

XX

XX

XX

Business services Implementation and other

2012

2013

2014

Source: Athena Health Annual Report, BIS Research

9.1.2.3 Financial Summary

The net revenue in 2014 was accounted to $XX million as compared to $XX million in 2013.

The sales have increased due to acquisition of Epocrates, Inc. which is recognized for

developing medical applications. These applications are used by health care providers to

diagnose and treat patients. The company operates through these two segments, mainly:

Business services and Implementation, among others.

BIS Research Sample



9.1.3 KEY DEVELOPMENT

Date Strategy Description

May 2015 Collaboration

AthenaHealth and ReviveHealth, a leading integrated

marketing communications firm,released findings on the

state of payer performance and provider perception of

those payers

April 2015 Partnership

AthenaHealth, Inc., and CareWell Urgent Care (CareWell)

entered into partnershipfor the connectivity and network

insight through AthenaOne cloud-based suite

April 2015 Collaboration

AthenaHealth, Inc. and Trinity Health collaborated to work

together to advance clinical integration and people-

centered care in the health system's multi-state

ambulatory network

April 2015 Product Launch

AthenaHealth, Inc. launched the athenaText app for Apple

Watch to provide the 'Digital Doctor'With messaging tool

inclusive of communication, clinical intelligence, and care

coordination

February

2015 Collaboration

AthenaHealth, Inc., and Beth Israel Deaconess Medical

Center (BIDMC)entered into an agreement to collaborate

on the development of athenahealth's acute care service

offering that will support the needs of large hospitals and

health systems across the U.S., and AthenaHealth. Ithas

also purchased webOMR, the web-based clinical

applications and Electronic Health Record (EHR) platform

developed by BIDMC

January

2015 Partnership

AthenaHealth and FCS partnered in strategic pilot

agreement to streamline administrative work and enhance

performance and financial results

January

2015 Acquisition

AthenaHealth announced the acquisition of RazorInsights, a

leader in cloud-based EHR and financial solutions for rural,

critical access, and community hospitals

December Event AthenaHealth Inc., announced that it will participate in the

BIS Research Sample




2014 33rd Annual J.P. Morgan Healthcare Conference

December

2014 Partnership

AthenaHealth Inc., and Women Health USA (WHUSA), a

leading provider of business and clinical management

services for physicians, entered into a strategic partnership

in which WHUSA has selected the athenaOne suite of

services to support its network of over 250 providers,

serving more than 300,000 patients in Connecticut

December

2014 Partnership

AthenaHealth Inc., and Granite healthcare Network(GHN)

entered into a partnership to deliver patient insight and

support value-based care and GHN has selected

athenahealth's cloud-based athenaCoordinator Enterprise

Population Manager to improve care quality and

coordination across GHN's growing network of risk-based

payment arrangements

September

2014 Business Expansion

AthenaHealth Inc., opened new offices in Georgia, San

Francisco, Atlanta, and California.

July 2014 Partnership

AthenaHealth Inc., and Arise Austin Medical Center(AAMC),

a physician-owned and operated hospital and its network of

outpatient facilities, entered into a partnership under which

AAMC has selected athenahealth's athenaCoordinator

Enterprise service to advance care coordination for its

more-than-100-physician network

June 2014 Recognition

Epocrates Inc., a subsidiary of AthenaHealth, announced

that for the fifth consecutive year, Epocrates leads the

digital health market in terms of medical reference

application reach on smartphones

May 2014 Partnership

AthenaHealth Inc., and Henry Schein Medical, the U.S.

Medical business ofthe world's largest provider of health

care products and services entered into a strategic

agreementto help physicians operate highly-efficient,

successful practices, as well as provide high-quality care

through the delivery and use of athenahealth's athenaOne

suite of EHR

BIS Research Sample




May 2014 Partnership

AthenaHealth Inc., and Summit Health Management

(Summit), a provider of innovative management services

for (SMG) to complement existing cloud-based revenue

cycle management service success

April 2014 Partnership

AthenaHealth Inc., and Steward Health Care System

(Steward) entered into a partnership in which Steward has

selected athenaCoordinator Enterprise to enable care

coordination for its employed providers and their patients

Source: AthenaHealth Website, BIS Research Analysis

BIS Research Sample



DISCLAIMER

BIS Research provides valuable market intelligence to an exclusive group of customers in

response to orders. The report is licensed for the customer's internal use only and is subject to

restrictions set henceforth. This document and its contents are confidential and may not be

further distributed, published or reproduced, in whole or in part, by any medium or in any form

for any purpose, without the express written consent of BIS Research. Customer will not

disclose the contents of the report, whether directly in any media or indirectly through

incorporation in a database, marketing list, report or otherwise, or use or permit the use of

Information to generate any statistical or other information that is or will be provided to third

parties; or voluntarily produce Information in legal proceedings.

Market reports are based on expectations, estimates and projections as of the date such

information is available. Any recommendation contained in this report may not be suitable for

all investors or businesses. The market conclusions drawn are necessarily based upon a

number of estimates and assumptions that, while considered reasonable by BIS Research as of

the date of such statements, are inherently subject to market fluctuations and business,

economic and competitive uncertainties and contingencies

For more details regarding permission, please contact us:

Email: [email protected]

Tel: +1 650 228 0182

sample - global mhealth (mobile health) market

Documents